Unicycive Therapeutics, Inc. (UNCY)
NASDAQ: UNCY · IEX Real-Time Price · USD
0.396
-0.004 (-1.00%)
Jul 22, 2024, 10:17 AM EDT - Market open
Unicycive Therapeutics Employees
Unicycive Therapeutics had 14 employees as of December 31, 2023. The number of employees increased by 2 or 16.67% compared to the previous year.
Employees
14
Change (1Y)
2
Growth (1Y)
16.67%
Revenue / Employee
n/a
Profits / Employee
-$2,701,071
Market Cap
33.92M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 14 | 2 | 16.67% |
Dec 31, 2022 | 12 | 3 | 33.33% |
Dec 31, 2021 | 9 | 8 | 800.00% |
Dec 31, 2020 | 1 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
Nutex Health | 800 |
Achilles Therapeutics | 215 |
Exagen | 179 |
Retractable Technologies | 151 |
Orgenesis | 146 |
Aadi Bioscience | 89 |
iCAD, Inc. | 69 |
IGC Pharma | 67 |
UNCY News
- 5 days ago - Unicycive Therapeutics Granted Patent on UNI-494 to Treat Acute Kidney Injury by the United States Patent and Trademark Office (USPTO) - GlobeNewsWire
- 11 days ago - Unicycive Therapeutics to Participate in Fireside Chat at the H.C. Wainwright 3rd Annual Kidney Virtual Conference - GlobeNewsWire
- 12 days ago - Unicycive Therapeutics Announces Initial Positive Patient Satisfaction Findings from Pivotal Clinical Trial of Oxylanthanum Carbonate (OLC) - GlobeNewsWire
- 21 days ago - Unicycive Therapeutics Joins Russell Microcap® Index - GlobeNewsWire
- 27 days ago - Unicycive Therapeutics Achieves Study Objective in Oxylanthanum Carbonate (OLC) Pivotal Clinical Trial - GlobeNewsWire
- 7 weeks ago - Unicycive Therapeutics Delivers Multiple Presentations on Oxylanthanum Carbonate (OLC) and UNI-494 at the European Renal Association Congress - GlobeNewsWire
- 2 months ago - Unicycive Therapeutics to Participate in a Fireside Chat at the Lytham Partners Spring 2024 Investor Conference - GlobeNewsWire
- 2 months ago - Unicycive Therapeutics Presents Bioequivalence Data on Oxylanthanum Carbonate (OLC) at the National Kidney Foundation Spring Clinical Meeting - GlobeNewsWire